| Lastest Insider Transactions Of REPLIGEN CORP ( RGEN ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| RGEN | REPLIGEN CORP | Loeillot Olivier | Chief Executive Officer | 2026-09-03 | Sell | 3,035 | 165.90 | 503,507 | 2026-09-08 16:13:40 |
| RGEN | REPLIGEN CORP | Garland Jason K | CFO | 2026-07-16 | Sell | 530 | 150.00 | 79,500 | 2026-07-17 16:40:41 |
| RGEN | REPLIGEN CORP | Garland Jason K | CFO | 2026-06-25 | Sell | 733 | 145.00 | 106,285 | 2026-06-26 16:05:11 |
| RGEN | REPLIGEN CORP | MUIR GLENN P | Directior | 2026-05-07 | Option Exercise | 2,434 | 38.76 | 94,342 | 2026-05-08 14:48:02 |
| RGEN | REPLIGEN CORP | MUIR GLENN P | Directior | 2026-05-07 | Option Exercise | 2,434 | 38.76 | 94,342 | 2026-05-08 14:48:02 |
| RGEN | REPLIGEN CORP | Loeillot Olivier | Chief Executive Officer | 2026-04-21 | Sell | 3,832 | 140.00 | 536,480 | 2026-04-22 13:26:04 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2025-12-17 | Sell | 275 | 161.00 | 44,275 | 2025-12-18 16:30:18 |
| RGEN | REPLIGEN CORP | MUIR GLENN P | Directior | 2025-12-16 | Option Exercise | 3,366 | 26.12 | 87,920 | 2025-12-17 16:30:06 |
| RGEN | REPLIGEN CORP | Loeillot Olivier | Chief Executive Officer | 2025-11-25 | Sell | 7,041 | 170.00 | 1,196,970 | 2025-11-26 16:30:04 |
| RGEN | REPLIGEN CORP | Bylund James | Chief Operating Officer | 2025-11-18 | Sell | 2,191 | 151.21 | 331,301 | 2025-11-19 16:30:11 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-11-13 | Sell | 20,000 | 154.61 | 3,092,278 | 2025-11-14 16:30:08 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-11-13 | Option Exercise | 2,952 | 33.87 | 99,984 | 2025-11-14 16:30:08 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-11-12 | Sell | 25,000 | 156.88 | 3,921,940 | 2025-11-13 16:30:08 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-11-12 | Option Exercise | 25,000 | 33.87 | 846,750 | 2025-11-13 16:30:08 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-09-10 | Sell | 29,111 | 120.52 | 3,508,389 | 2025-09-11 14:55:01 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-09-10 | Option Exercise | 20,000 | 33.87 | 677,400 | 2025-09-11 14:55:01 |
| RGEN | REPLIGEN CORP | Madaus Martin D | Directior | 2025-08-08 | Buy | 1,800 | 112.13 | 201,830 | 2025-08-12 12:47:07 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-05-15 | Sell | 26,447 | 123.71 | 3,271,688 | 2025-05-16 15:02:50 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-03-17 | Sell | 26,756 | 152.51 | 4,080,663 | 2025-03-19 16:21:04 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2025-03-17 | Option Exercise | 26,756 | 54.73 | 1,464,267 | 2025-03-19 16:21:04 |
| RGEN | REPLIGEN CORP | Pax Margaret | Directior | 2025-03-17 | Buy | 250 | 150.69 | 37,673 | 2025-03-18 15:58:05 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2024-12-05 | Option Exercise | 11,808 | 33.87 | 399,937 | 2024-12-05 20:26:45 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2024-11-21 | Sell | 24,246 | 139.67 | 3,386,439 | 2024-11-22 16:52:20 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2024-11-21 | Option Exercise | 24,246 | 33.87 | 821,212 | 2024-11-22 16:52:20 |
| RGEN | REPLIGEN CORP | MUIR GLENN P | Directior | 2024-11-19 | Option Exercise | 19,000 | 36.29 | 689,510 | 2024-11-20 14:29:56 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2024-09-10 | Sell | 22,191 | 145.37 | 3,225,928 | 2024-09-12 11:35:31 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Directior | 2024-09-10 | Option Exercise | 10,000 | 33.87 | 338,700 | 2024-09-12 11:35:31 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Option Exercise | 175 | 86.10 | 15,068 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-08-02 | Sell | 7,148 | 159.35 | 1,139,016 | 2024-08-05 21:56:01 |
| RGEN | REPLIGEN CORP | Madaus Martin D | Directior | 2024-06-14 | Buy | 1,615 | 124.94 | 201,776 | 2024-06-14 18:07:59 |
| RGEN | REPLIGEN CORP | BARTHELEMY NICOLAS | Directior | 2024-06-14 | Buy | 1,200 | 125.45 | 150,540 | 2024-06-14 17:42:58 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-06-14 | Buy | 2,000 | 124.08 | 248,160 | 2024-06-14 17:41:04 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2024-06-14 | Option Exercise | 2,953 | 67.71 | 199,948 | 2024-06-14 17:33:10 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-05-21 | Sell | 20,072 | 168.26 | 3,377,283 | 2024-05-22 17:14:27 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-03-11 | Sell | 3,517 | 193.73 | 681,348 | 2024-03-12 20:24:20 |
| RGEN | REPLIGEN CORP | KURIYEL RALF | Senior VP, R&D | 2024-03-11 | Option Exercise | 1,271 | 86.10 | 109,433 | 2024-03-12 20:24:20 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-03-08 | Sell | 16,707 | 197.44 | 3,298,632 | 2024-03-11 19:43:36 |
| RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Officer | 2024-03-08 | Option Exercise | 1 | 16.55 | 17 | 2024-03-11 19:43:36 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2024-02-27 | Sell | 1,000 | 193.35 | 193,350 | 2024-02-28 21:56:23 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2024-02-27 | Option Exercise | 4,626 | 42.07 | 194,616 | 2024-02-28 21:56:23 |
| RGEN | REPLIGEN CORP | Bylund James | Chief Operating Officer | 2024-02-23 | Sell | 4,373 | 198.08 | 866,204 | 2024-02-26 20:38:26 |
| RGEN | REPLIGEN CORP | Bylund James | Chief Operating Officer | 2024-02-23 | Option Exercise | 940 | 94.33 | 88,670 | 2024-02-26 20:38:26 |
| RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | 2023-11-10 | Sell | 3,788 | 147.13 | 557,328 | 2023-11-13 17:10:34 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2023-08-29 | Sell | 850 | 171.38 | 145,673 | 2023-08-30 16:06:03 |
| RGEN | REPLIGEN CORP | DAWES KAREN A | Directior | 2023-08-29 | Option Exercise | 7,392 | 18.12 | 133,943 | 2023-08-30 16:06:03 |
| RGEN | REPLIGEN CORP | Madaus Martin D | Directior | 2023-03-24 | Buy | 1,500 | 158.84 | 238,260 | 2023-05-08 21:15:01 |
| RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Officer | 2023-02-16 | Sell | 5,647 | 200.00 | 1,129,400 | 2023-02-17 16:56:31 |
| RGEN | REPLIGEN CORP | EGLINTON MANNER CARRIE | Directior | 2022-03-16 | Buy | 625 | 175.02 | 109,388 | 2022-12-15 06:55:39 |
